Search

As the key player of a new restriction modification system, DNA phosphorothioate (PT) modification, which swaps oxygen for sulfur on the DNA backbone, protects the bacterial host from foreign DNA invasion. The identification of PT sites helps us understand its physiological defense mechanisms, but accurately quantifying this dynamic modification remains a challenge. Herein, we report a simple quantitative analysis method for optical mapping of PT sites in the single bacterial genome. DNA molecules are fully stretched and immobilized in a microfluidic chip by capillary flow and electrostatic interactions, improving the labeling efficiency by maximizing exposure of PT sites on DNA while avoiding DNA loss and damage. After screening 116 candidates, we identified a bifunctional chemical compound, iodoacetyl-polyethylene glycol-biotin, that can noninvasively and selectively biotinylate PT sites, enabling further labeling with streptavidin fluorescent nanoprobes. With this method, PT sites in PT

Isolation of circulating tumor cells (CTCs) from patients is a challenge due to the rarity of CTCs. Recently, various platforms to capture and release CTCs for downstream analysis have been developed. However, most of the reported release methods provide external stimuli to release all captured cells, which lead to lack of specificity in the pool of collected cells, and the external stimuli may affect the activity of the released cells. Here, we presented a simple method for single-cell recovery to overcome the shortcomings, which combined the nanostructures with a photocurable hydrogel, chondroitin sulfate methacryloyl (CSMA). In brief, we synthesized gelatin nanoparticles (Gnps) and modified them on flat glass (Gnp substrate) for the specific capture of CTCs. A 405 nm laser was projected onto the selected cells, and then CSMA was cured to encapsulate the selected CTCs. Unselected cells were removed with MMP-9 enzyme solution, and selected CTCs were recovered using a microcapillary. Finally, the photocurable hydrogel-encapsulated cells were analyzed by nucleic acid detection. In addition, the results suggested that the isolation platform showed good biocompatibility and successfully achieved the isolation of selected cells. In summary, our light-induced hydrogel responsive platform holds certain potential for clinical applications.

Fetal nucleated red blood cells (fNRBCs) in maternal peripheral blood containing the whole genetic information of the fetus may serve for noninvasive pregnant diagnostics (NIPD). However, the fetal cell-based NIPD is seriously limited by the poor purity of the isolated fNRBCs. Recently, the biomimetic cell membrane-camouflaged nanoparticles containing outstanding features have been widely used to detect and isolate rare cells from the peripheral blood samples. In this work, enythrocyte (RBC) and leukocyte (WBC) membranes are fused and coated onto magnet nanoparticles and then modified with anti-CD147 to isolate fNRBCs from the maternal peripheral blood with significant efficiency (∼90%) and purity (∼87%) in simulated spiked blood samples. Further, fNRBCs were isolated and identified from a series of maternal peripheral blood samples coming from pregnant women of 11-13 gestational weeks, and different chromosomal aneuploidies were diagnosed using fNRBCs isolated from maternal blood in early pregnancy. Our strategy may offer additional opportunity to overcome the limitations of current cell-based NIPD platforms.

Circulating tumor cells (CTCs) are rare, meaning that current isolation strategies can hardly satisfy efficiency and cell biocompatibility requirements, which hinders clinical applications. In addition, the selected cells require immunofluorescence identification, which is a time-consuming and expensive process. Here, we developed a method to simultaneously separate and identify CTCs by the integration of optical force and fluorescent microspheres. Our method achieved high-purity separation of CTCs without damage through light manipulation and avoided additional immunofluorescence staining procedures, thus achieving rapid identification of sorted cells. White blood cells (WBCs) and CTCs are similar in size and density, which creates difficulties in distinguishing them optically. Therefore, fluorescent PS microspheres with high refractive index (RI) are designed here to capture the CTCs (PS-CTCs) and increase the average index of refraction of PS-CTCs. In optofluidic chips, PS-CTCs were propelled to the collection channel from the sample mixture, under the radiation of light force. Cells from the collection outlet were easily identified under a fluorescence microscope due to the fluorescence signals of PS microspheres. This method provides an approach for the sorting and identification of CTCs, which holds great potential for clinical applications in early diagnosis of disease.

Blood tests have been a powerful tool for the clinical analysis of many diseases. With the advances in microfluidic technology, two more specific indicators from the circulation system, namely, emerging "liquid biopsy" of circulating tumor cells (CTCs) and fetal nucleated red blood cells (fNRBCs), can be screened and analyzed as a simple blood test for the noninvasive diagnosis of cancers as well as fetal disorders. The unique feature of precisely manipulating a trace of fluid endows microfluidic devices with the ability to isolate CTCs or fNRBCs from numerous blood cells with high performance, which undoubtedly facilitates biomedical applications of these two kinds of rare cells. In this review, advanced developments in microfluidic technologies focusing on the detection and sorting of rare CTCs and fNRBCs from peripheral blood are summarized. The development of microfluidic devices incorporated with various multifunctional microstructures and nanomaterials for enhancing the sensitivity, purity, and viability of CTC or fNRBC detection enables CTC molecular analysis and fNRBC-based noninvasive prenatal diagnosis (NIPD). These microfluidics-based approaches provide great potential opportunities in noninvasive cancer diagnosis or NIPD applications.

The isolation and analysis of scarce circulating tumor cells (CTCs) with immunomagnetic nanoparticles (IMNs) have shown promising outcomes in noninvasive cancer diagnosis. However, the IMNs adsorb nonspecific proteins after entering into biofluids and the formed protein coronas cover surface targeting ligands, limiting the detection efficiency of IMNs. In addition, the interaction between surface targeting ligands and white blood cells (WBCs) significantly limits the purity of CTCs isolated by IMNs. Furthermore, the interfacial collision of nanoparticles and cells has negative effects on the viability of isolated CTCs. All of these limitations synthetically restrict the isolation and analysis of rare CTCs for early diagnosis and precision medicine. Here, we proposed that surface functionalization of IMNs with neutrophil membranes can simultaneously reduce nonspecific protein adsorption, enhance the interaction with CTCs, reduce the distraction from WBCs, and improve the viability of isolated CTCs. In spiked blood samples, our neutrophil membrane-coated IMNs (Neu-IMNs) exhibited a superior separation efficiency from 41.36% to 96.82% and an improved purity from 40.25% to 90.68% when compared to bare IMNs. Additionally, we successfully isolated CTCs in 19 out of total 20 blood samples from breast cancer patients using Neu-IMNs and further confirmed the feasibility of the isolated CTCs for downstream cell sequencing. Our work provides a new perspective on engineered IMNs for efficient isolation and analysis of CTCs, paving the way for early noninvasive diagnosis of cancer.

Fetal nucleated red blood cells (fNRBC) in maternal peripheral blood has the potential for non-invasive prenatal diagnostics (NIPD), given its intrinsic nature carrying total genetic information of the fetus. Unfortunately, the scarcity of fNRBCs in maternal blood circulation greatly hinders the effective isolation of fNRBCs and its further uses for clinical prenatal diagnostics. Herein, we developed a gelatin nanoparticles (GNPs) decorated microchip that modified with anti-CD147 as specific capture antibody to efficiently isolate fNRBCs from maternal peripheral blood. The corrugated GNP nanocoating on the walls of the channel, together with herringbone grooves in the continuous curved channel design, produced enhanced interactions between fNRBC and the device for better cell capture performance. Furthermore, the captured cells could be gently released for subsequent off-chip analyses, using an enzymatic treatment to dissolve the biodegradable GNP nanocoating. Significant target cell capture efficiency (>80%), release efficiency (∼89%) and purity (∼85%) as well as a high viability of >90% were achieved using simulated spiked samples. fNRBCs were detected from a series of maternal peripheral blood samples ranging from 7 to 13 weeks of gestation, and the diagnostic application for fetal chromosomal disorders was demonstrated. Our strategy may provide new insights into developing an approach to recover fNRBCs from early pregnancy for improved cell-based NIPD.

An inorganic caesium cation was incorporated into perovskite to improve the performance and stability of solar cells with a hole-transport-material free structure in ambient air. A triple cation device with a champion power conversion efficiency of over 15% was achieved, exhibiting superior thermal, long-term and operational stabilities.

Hole transport material free (HTM-free) perovskite solar cells (PSCs) with carbon counter electrode have the advantages of low-cost, good efficiency and high stability. Here in this work, we demonstrate that incorporating Au@SiO2 core-shell NPs into TiO2 scaffold layer increases the power conversion efficiencies (PCEs) of PSCs by improving the light absorption and facilitating carrier transfer or separation through SPR effect. With the optimal concentration of 0.3 wt % Au@SiO2 incorporation, the average PCE of PSCs enhances to 13.85 ± 0.45% from the reference samples of 12.01 ± 0.44%, which is mainly caused by the improved short circuit current density.

Effective capture and release of circulating tumor cells (CTCs) with high viability is still a challenge in medical research. We design a novel approach with efficient yield and high cell activity for the capture and release of CTCs. Our platform is based on TiO2 nanorod arrays coated with transparent MnO2 nanoparticles. We use hydrothermal synthesis to prepare TiO2 nanorod arrays, the MnO2 nanoparticles are fabricated through in situ self-assembly on the substrate to form a monolayer and etched by oxalic acid with low concentration at room temperature. Up to 92.9% of target cells are isolated from the samples using our capture system and the captured cells can be released from the platform, the saturated release efficiency is 89.9%. Employing lower than 2 × 10-3 M concentration of oxalic acid to dissolve MnO2, the viability of MCF-7 cancer cells exceed 90%. Such a combination of the two-dimensional and three-dimensional platforms provides a new approach isolate CTCs from patient blood samples.

Background: Circulating tumor cells (CTCs) are a burgeoning topic in cancer biomarker discovery research with minimal invasive blood draws. CTCs can be used as potential biomarkers for disease prognosis, early cancer diagnosis and pharmacodynamics. However, the extremely low abundance of CTCs limits their clinical utility because of technical challenges such as the isolation and subsequent detailed molecular and functional characterization of rare CTCs from patient blood samples. Methods: In this study, we present a novel density gradient centrifugation method employing biodegradable gelatin nanoparticles coated on silicon beads for the isolation, release, and downstream analysis of CTCs from colorectal and breast cancer patients. Results: Using clinical patient/spiked samples, we demonstrate that this method has significant CTC-capture efficiency (>80%) and purity (>85%), high CTC release efficiency (94%) and viability (92.5%). We also demonstrate the unparalleled robustness of our method in downstream CTC analyses such as the detection of PIK3CA mutations. Conclusion: The efficiency and versatility of the multifunctional density microbeads approach provides new opportunities for personalized cancer diagnostics and treatments.

Here, we present a platelet-facilitated photothermal tumor therapy (PLT-PTT) strategy, in which PLTs act as carriers for targeted delivery of photothermal agents to tumor tissues and enhance the PTT effect. Gold nanorods (AuNRs) were first loaded into PLTs by electroporation and the resulting AuNR-loaded PLTs (PLT-AuNRs) inherited long blood circulation and cancer targeting characteristics from PLTs and good photothermal property from AuNRs. Using a gene-knockout mouse model, we demonstrate that the administration of PLT-AuNRs and localizing laser irradiation could effectively inhibit the growth of head and neck squamous cell carcinoma (HNSCC). In addition, we found that the PTT treatment augmented PLT-AuNRs targeting to the tumor sites and in turn, improved the PTT effects in a feedback manner, demonstrating the unique self-reinforcing characteristic of PLT-PTT in cancer therapy.

Anatase TiO2 ultra-thin nanosheets (TiO2-NS) are synthesized by a facile hydrothermal method. Several merits are realized when employing the prepared TiO2-NS as lithium ion battery anode material, compared to TiO2 nanoparticles. Firstly, the as-prepared TiO2-NS has high charge capacities and a specific surface area up to 98.8 m2g−1, which is beneficial for the insertion of lithium ion. Secondly, the large specific surface area is helpful in enlarging the electrode/electrolyte interfacial area. Finally, the EIS result verifies short electron transfer paths. More importantly, the stability of the nanosheet structure is indirectly confirmed by the excellent cycling performance of charge capacity and the curve of charge capacities versus cycle number at different current densities. After galvanostatic charge/discharge of the batteries for 1000 cycles, the HRTEM images of post-mortem batteries directly reveal a good reversibility of the lithium ion insertion/extraction process aided by TiO2-NS. Thus, all these advantages and the special structure facilitate an excellent cycling performance: the charge capacity with the maximum value of 250 mAh g−1 keeps half after 2000 cycles at a current density of 840 mA g−1 (5 C).

The recovery of rare single circulating tumor cells (CTCs) from patients has great potential to facilitate the study of cell heterogeneity and cancer metastasis, which may promote the development of individualized cancer immunotherapy. Herein, a versatile single-cell recovery approach that utilizes an acoustic droplet-induced enzyme responsive platform for the capture and on-demand release of single CTCs is proposed. The platform combines a multifunctional enzyme-responsive gelatin nanoparticle (GNP)-decorated substrate (GNP-chip) for specific capture with an acoustic droplet positioning technique to realize on-demand release of single CTCs. The acoustic droplet dispenser is employed to generate oxidized alginate microdroplets containing the MMP-9 enzyme (OA-MMP-9) with controllable size and precise positioning upon the cell-attached GNP-chip, allowing controlled cell-surface biodegradation under enzymatic reactions followed by calcium chloride (CaCl2) solution treatment to form single-cell encapsulated calcium alginate hydrogels. Benefitting from the existence of hydrogels, the released cells could be efficiently recovered by microcapillary. Results demonstrate that the encapsulated cells maintain good cell morphology in the hydrogels, which allow further single-cell nucleic acid analysis. As a proof-of-concept platform, this approach enables reliable and efficient retrieval of single CTCs and holds the potential for versatility in single-cell analysis systems.

Circulating tumor cells (CTCs) are important for the detection and treatment of cancer. Nevertheless, a low density of circulating tumor cells makes the capture and release of CTCs an obstacle. In this work, TiO

The development of tin-based perovskite solar cells (PSCs) is a promising approach to meet the demand of eco-friendly, lead-free perovskite photovoltaics. Limited to the poor chemical stability of tin perovskites, tin-based PSCs usually have to be fabricated with an inverted device structure and both the device efficiency and stability are highly dependent on the selection of hole transport materials (HTMs). Here, we report the synthesis of inorganic nickel oxide (NiO x ) nanoparticles (NPs) via a soft base precipitation method, which enables us to obtain highly dispersed NiO x NPs over a wide pH window. The as-prepared NiO x NPs are employed as the HTM for formamidinium tin iodide (FASnI3) PSCs, resulting in excellent device efficiency (∼8%) and stability (1200 h). Our study offers a facile strategy for mass production of NiO x NPs and easy access to efficient and robust inorganic HTMs that could further boost the development of high performance tin-based PSCs.

Upconversion nanoparticles (UCNPs), with fascinating optical and chemical features, are a promising new generation of fluorescent probes. Although UCNPs have been widely used in diagnosis and therapy, there is an unmet need for a simple and effective surface engineering method that can produce cancer-targeting UCNPs. Here, we show that by coating particles with macrophage membranes, it becomes possible to utilize the adhesion between macrophages and cancer cells for effective cancer targeting. Natural macrophage membranes along with their associated membrane proteins were reconstructed into vesicles and then coated onto synthetic UCNPs. The resulting macrophage membrane-camouflaged particles (MM-UCNPs) exhibited effective cancer targeting capability inherited from the source cells and were further used for enhanced in vivo cancer imaging. Finally, the blood biochemistry, hematology testing and histology analysis results suggested a good in vivo biocompatibility of MM-UCNPs. The combination of synthetic nanoparticles with biomimetic cell membranes embodies a novel design strategy toward developing biocompatible nanoprobes for potential clinical applications. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 521-530, 2017.

The two-step spin coating process produces rough perovskite surfaces in ambient condition with high humidity, which are unfavorable for the contact between the perovskite film and the low temperature carbon electrode. To tackle this problem, multi-walled carbon nanotubes (MWCNTs) are embedded into the perovskite layer. The MWCNTs can act as charge transport high way between individual perovskite nanoparticles and facilitate the collection of the photo-generated holes by the carbon electrode. Longer carrier lifetime is confirmed in the perovskite solar cells with addition of MWCNTs using open circuit voltage decay measurement. Under optimized concentration of MWCNT, average power conversion efficiency of 11.6% is obtained in hole transport material free perovskite solar cells, which is boosted by ∼15% compared to solar cells without MWCNT.

In this paper, autofluorescent gelatin nanoparticles were synthesized as matrix metalloproteinase (MMP) responsive probes for cancer cell imaging. A modified two-step desolvation method was employed to generate these nanoparticles whose size was controllable and had stable autofluorescence. As glutaraldehyde was introduced as the crosslinking agent, the generation of Schiff base (CN) and double carbon bond (CC) between glutaraldehyde and gelatin endowed these gelatin nanoparticles distinct autofluorescence. Considering MMPs were usually overexpressed on the surface of cancer cells and they had degradation ability toward gelatin, we utilized these nanoparticles as imaging probes to responsively monitor the MMP metabolism of cancer cells according to the luminance change. As fluorescent probes, these nanoparticles had facile synthesis procedure and good biocompatibility, and provided a smart strategy to monitor cancer cell behaviors. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 2854-2860, 2016.

A mesoporous SiO2 layer is successfully introduced into the hole transport material free perovskite solar cells by spin-coating a SiO2 paste onto the TiO2 scaffold layer. This SiO2 layer can act as an insulating layer and effectively inhibit the charge recombination between the TiO2 layer and carbon electrode. The variation of power conversion efficiencies with the thickness of SiO2 layer is studied here. Under optimized SiO2 thickness, perovskite solar cell fabricated on the TiO2/SiO2 film shows a superior power conversion efficiency of ∼12% and exhibits excellent long time stability for 30 days.

An optimized two-step sequential deposition method to fabricate hole-transport-layer-free carbon-based methyl ammonium lead bromide (MAPbBr3) perovskite solar cells is reported. Small amounts of MABr are introduced into the PbBr2 precursor solution during the first step to prepare MAPbBr3 perovskite films (labeled as MAPB-xMABr), which promotes the conversion of PbBr2 into perovskite phase and results in denser perovskite films with increased crystallinity, lower trap density, and longer carrier lifetime. After optimization, a maximum power conversion efficiency (PCE) of 7.64% (VOC = 1.36 V) is obtained for MAPB-0.2MABr based solar cells. Significantly, the non-encapsulated devices exhibit excellent long-term stability in ambient air (25–30 °C and 20–30% relative humidity), showing no degradation after a year’s exposure. While, it also shows superior thermal stability with PCE retaining 95% of the initial efficiency after 120 h under thermal stress of 80 °C and 40–70% relative humidity.

Two dimensional materials have promising benefits in photoelectronic devices, including facilitating charge transport and reducing defects in perovskite solar cells (PSCs) and photodetectors (PDs) through interface engineering. Herein, a two dimension polymeric material of graphitic carbon nitride quantum dots (g-CNQDs) interlayer is used to modify the SnO2/perovskite interface in both ambient PSCs and PDs to improve the overall performance. The introduction of g-CNQD layer improves the crystalline quality of sequential perovskite absorber with high phase purity, less grain boundaries, low trap states and suppressed carrier recombination due to the intrinsic cross-linkable feature and relatively smooth surface of g-CNQD. As a result, with optimal modification, fully air-processed PSC reached a champion power conversion efficiency of 21.23% with negligible hysteresis, and the PDs had remarkable performance enhancement. Moreover, our PSCs have good stability in ambient air, keeping over 90% of the initial efficiency after 30 days’ exposure.

Stable hosts containing pre-stored metallic lithium (Li) are typically used to tackle irregular dendrite formation and infinite relative volume changes of lithium metal anodes. In this sense, oversimplified molten Li infusion strategies have been widely proposed to build lithiophilic architectures with uncontrollable amount and configuration of metallic Li in obtained hosts. In this work, tin oxide (SnO2) deposited Ni foam (SNF) with superior molten Li wettability is employed to construct two distinct lithiophilic architectures namely, Li coated SNF skeletons and Li infiltrated SNF frameworks. The cycling stability and dendritic behavior of these lithiophilic architectures are systematically compared. Both of these lithiophilic architectures significantly outperformed bare Li foils in terms of cycling performance and electrode dimension stability. The fully covered lithiophilic host with Li infiltrated SNF frameworks shows much better cycling stability and lower hysteresis than the porous lithiophilic host with Li coated skeletons, especially at high current densities and large stripping/plating capacities. In full-cell configurations, the batteries based on Li infiltrated SNF frameworks also show significantly higher rate capabilities than Li coated SNF skeletons counterpart. Our results provide a better understanding to design stable lithiophilic hosts for high-rate and high-capacity lithium metal anodes.

Filtration of circulating tumor cells (CTCs) in peripheral blood is of proven importance for early cancer diagnosis, treatment monitoring, metastasis diagnosis, and prognostic evaluation. However, currently available strategies for enriching CTCs, such as magnetic activated cell sorting (MACS), face serious problems with purity due to nonspecific interactions between beads and leukocytes in the process of capturing. In the present study, the tumor-targeting molecule folic acid (FA) and magnetic nanoparticles (MNPs) were coated on the surface of red blood cells (RBCs) by hydrophobic interaction and chemical conjugation, respectively. The resulting engineered RBCs rapidly adhered to CTCs and the obtained CTC-RBC conjugates were isolated in a magnetic field. After treatment with RBC lysis buffer and centrifugation, CTCs were released and captured. The duration of the entire process was less than three hours. Cell counting showed that the capture efficiency was above 90% and the purity of the obtained CTCs was higher than 75%. The performance of the proposed method exceeded that of MACS® beads (80% for capture efficiency and 20% for purity) under the same conditions. The obtained CTCs could be successfully re-cultured and proliferated in vitro. Our engineered RBCs have provided a novel method for enriching rare cells in the physiological environment.

Recently, red blood cell (RBC) membrane-coated nanoparticles have attracted much attention because of their excellent immune escapability; meanwhile, gold nanocages (AuNs) have been extensively used for cancer therapy due to their photothermal effect and drug delivery capability. The combination of the RBC membrane coating and AuNs may provide an effective approach for targeted cancer therapy. However, few reports have shown the utilization of combining these two technologies. Here, we design erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy. First, anti-EpCam antibodies were used to modify the RBC membranes to target 4T1 cancer cells. Second, the antitumor drug paclitaxel (PTX) was encapsulated into AuNs. Then, the AuNs were coated with the modified RBC membranes. These new nanoparticles were termed EpCam-RPAuNs. We characterized the capability of the EpCam-RPAuNs for selective tumor targeting via exposure to near-infrared irradiation. The experimental results demonstrate that EpCam-RPAuNs can effectively generate hyperthermia and precisely deliver the antitumor drug PTX to targeted cells. We also validated the biocompatibility of the EpCam-RAuNs in vitro. By combining the molecularly modified targeting RBC membrane and AuNs, our approach provides a new way to design biomimetic nanoparticles to enhance the surface functionality of nanoparticles. We believe that EpCam-RPAuNs can be potentially applied for cancer diagnoses and therapies.

Nanotechnology possesses the potential to revolutionize the diagnosis and treatment of tumors. The ideal nanoparticles used for in vivo cancer therapy should have long blood circulation times and active cancer targeting. Additionally, they should be harmless and invisible to the immune system. Here, we developed a biomimetic nanoplatform with the above properties for cancer therapy. Macrophage membranes were reconstructed into vesicles and then coated onto magnetic iron oxide nanoparticles (Fe3O4 NPs). Inherited from the Fe3O4 core and the macrophage membrane shell, the resulting Fe3O4@MM NPs exhibited good biocompatibility, immune evasion, cancer targeting and light-to-heat conversion capabilities. Due to the favorable in vitro and in vivo properties, biomimetic Fe3O4@MM NPs were further used for highly effective photothermal therapy of breast cancer in nude mice. Surface modification of synthetic nanomaterials with biomimetic cell membranes exemplifies a novel strategy for designing an ideal nanoplatform for translational medicine.

As "liquid biopsies", circulating tumor cells (CTCs) have been thought to hold significant insights for cancer diagnosis and treatment. Despite the advances of microfluidic techniques that improve the capture of CTCs to a certain extent, recovering the captured CTCs with enhanced purity at the same time remains a challenge. Here, by combining on-chip purification and off-chip enzymatic treatment, we demonstrate a two-stage strategy to enhance the purity of captured cancer cells from blood samples. The on-chip purification introduces a stirring flow to increase the capture sensitivity and decrease nonspecifically bounded cells. The off-chip enzymatic treatment enables the cancer cells to be released from the attached magnetic beads, further improving the purity and enabling next reculture. For the proof-of-concept study, spiked cancer cells are successfully obtained from unprocessed whole blood with high recovery rate (∼68%) and purity (∼61%), facilitating subsequent RNA expression analysis.

Liquid electrolytes employing fluorescent perylene are prepared and applied in dye sensitized solar cells (DSSCs). Due to the excellent down-shifting property of perylene, photons with short wavelength (from about 350 to 440 nm) can be absorbed and then converted to ones with longer wavelength (from 450 nm to 550 nm) which can be more efficiently utilized by DSSCs. As a result, device with optimal concentration of 0.05 M perylene presents an efficient improvement in the short-circuit current density ( J sc ), leading to an increase of 11.6% in the power conversion efficiency (PCE) compared with the reference DSSC based on control electrolyte.

In this work, a single-layer electric separator based on droplet microfluidics is demonstrated for cell sorting. We introduce a droplet pre-charging stratagem to reduce the voltages needed and increase droplet maneuverability. This stratagem and subsequent sorting process is implemented due to the effect of analogous uniform electric fields, which are generated by the 3D electrodes fabricated through injecting conductive silver paste into chambers in the PDMS layer. The mechanism of this droplet pre-charging process is experimentally verified and the amount of the inductive charges is quantitatively calculated. We also analyze the influence of the interaction between droplet size and channel walls on the manipulations of charge-carried droplets under certain electric fields. After parameter optimization, droplets with single cell encapsulated inside are separated out from other ones using this separator, and cell viability assay indicates that good cell status is maintained through the whole electric cascade.

Upconversion nanoparticles (UCNPs) with superior optical and chemical features have been broadly employed for in vivo cancer imaging. Generally, UCNPs are surface modified with ligands for cancer active targeting. However, nanoparticles in biological fluids are known to form a long-lived "protein corona", which covers the targeting ligands on nanoparticle surface and dramatically reduces the nanoparticle targeting capabilities. Here, for the first time, we demonstrated that by coating UCNPs with red blood cell (RBC) membranes, the resulting cell membrane-capped nanoparticles (RBC-UCNPs) adsorbed virtually no proteins when exposed to human plasma. We further observed in various scenarios that the cancer targeting ability of folic acid (FA)-functionalized nanoparticles (FA-RBC-UCNPs) was rescued by the cell membrane coating. Next, the FA-RBC-UCNPs were successfully utilized for enhanced in vivo tumor imaging. Finally, blood parameters and histology analysis suggested that no significant systematic toxicity was induced by the injection of biomimetic nanoparticles. Our method provides a new angle on the design of targeted nanoparticles for biomedical applications.

The properties of nanomaterials are highly dependent on their size, shape and composition. Compared with zero-dimensional nanoparticles, the increased dimension of a one-dimensional silver nanowire (AgNW/Ag NW) leads to extra challenges on synthesizing it with controllable sizes. Here, a convenient way for the synthesis of AgNWs with tunable sizes has been developed simply by adjusting the amount of salt additives, i.e., ferric chloride (FeCl

Three-dimensional branched TiO2 architectures (3D BTA) with controllable morphologies were synthesized via a facile template-free one-pot solvothermal route. The volume ratio of deionized water (DI water) and diethylene glycol in solvothermal process is key to the formation of 3D BTA assembled by nanowire-coated TiO2 dendrites, which combines the advantages of 3D hierarchical structure and 1D nanoscale building blocks. Benefiting from such unique structural features, the BTA in full bloom achieved significantly increased specific surface areas and shortened Li(+) ion/electrons diffusion pathway. The lithium-ion batteries based on BTA in full bloom exhibited remarkably enhanced reversible specific capacity and rate performance, attributing to the high contact area with the electrolyte and the short solid state diffusion pathway for Li(+) ion/electrons promoting lithium insertion and extraction.

In this paper, autofluorescent gelatin nanoparticles were synthesized as matrix metalloproteinase (MMP) responsive probes for cancer cell imaging. A modified two-step desolvation method was employed to generate these nanoparticles whose size was controllable and had stable autofluorescence. As glutaraldehyde was introduced as the crosslinking agent, the generation of Schiff base (CN) and double carbon bond (CC) between glutaraldehyde and gelatin endowed these gelatin nanoparticles distinct autofluorescence. Considering MMPs were usually overexpressed on the surface of cancer cells and they had degradation ability toward gelatin, we utilized these nanoparticles as imaging probes to responsively monitor the MMP metabolism of cancer cells according to the luminance change. As fluorescent probes, these nanoparticles had facile synthesis procedure and good biocompatibility, and provided a smart strategy to monitor cancer cell behaviors. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 2854-2860, 2016.

Biomimetic cell-membrane-camouflaged particles with desirable features have been widely used for various biomedical applications. However, there are few reports on employing these particles for cancer drug delivery due to the failure of the membrane coatings to be efficiently degraded in the tumor microenvironment which hampers the drug release. In this work, core-shell SiO2 @TiO2 nanoparticles with enhanced photocatalytic activity are used for controlled degradation of surface erythrocyte membrane coatings. The antitumor drug docetaxel is encapsulated into nanocarriers to demonstrate the controlled drug release under ultraviolet irradiation, and the drug-loaded nanoparticles are further used for enhanced cancer cell therapy. Here, a simple but practical method for degradation of cell membrane coatings is presented, and a good feasibility of using cell membrane-coated nanocarriers for controlled drug delivery is demonstrated.

In this work, we developed a shape-controllable nozzle inside a multilayer PDMS microchip. The nozzle was able to control the shape of the fluid channel in three dimensions. All the four walls of the fluid channel were comprised of pneumatic PDMS membrane valves, and their deformation was controlled by air pressure. As both the limitation of the fluid flux and the shape of the fluid channel were adjustable spatially in three dimensions, this valve-based nozzle generated droplets with less response time and in a more effectively controlled manner comparing to conventional droplet devices. It could also function as a microinjector to modulate the compositions of droplets precisely and continuously. In addition, the nozzle was able to form a specific shape to generate core–shell particles.

We report on the feasible fabrication of microfluidic devices for ferroelectric polymers' synthesis in a rapid and stable fashion. Utilizing micro-mixing and flow-focusing in microchannels, poly(vinylidene fluoride-trifluoroethylene) and copper phthalocyanine are uniformly dispersed in one hydrogel particle, which are then demonstrated to immediate and complete on-chip steady polymerization by moderate ultraviolet treatment. The advantage of our droplet-based microfluidic devices is generating versatile particles from simple spheres to disks or rods, and the lengths of particles can be precisely tuned from 30 to 400 μm through adjusting the flow rates of both disperse and oil phases. In addition, this mixed technique allows for the continuous production of dielectric microparticles with controlled dielectric properties between 10 and 160. Such a microfluidic device offers a flexible platform for multiferroic applications.